Genetic Technologies Stock Investor Sentiment
| GENE Stock | USD 2.25 0.14 5.86% |
About 61% of Genetic Technologies' investor base is looking to short. The analysis of overall sentiment of trading Genetic Technologies stock suggests that many investors are alarmed at this time. Genetic Technologies' investor sentiment overview provides quick insight into current market opportunities from investing in Genetic Technologies. The current market sentiment, together with Genetic Technologies' historical and current headlines, can help investors time the market. In addition, many technical investors use Genetic Technologies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Genetic Technologies stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Genetic daily returns and investor perception about the current price of Genetic Technologies as well as its diversification or hedging effects on your existing portfolios.
Genetic |
Genetic Technologies Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Genetic Technologies can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Genetic Technologies that are available to investors today. That information is available publicly through Genetic media outlets and privately through word of mouth or via Genetic internal channels. However, regardless of the origin, that massive amount of Genetic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Genetic Technologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Genetic Technologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Genetic Technologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Genetic Technologies alpha.
Genetic Technologies Performance against NYSE Composite
Price Growth (%) |
| Timeline |
1 | Global Consumer Genomics Market Size To Worth USD 7.48 Billion By 2033 CAGR of 18.85 | 03/12/2024 |
2 | GTG Global Collaborations and Innovation Update | 03/26/2024 |
3 | Genetic Technologies Share Price Passes Above 200 Day Moving Average of 2.77 - Defense World | 04/04/2024 |
4 | Acquisition by Hennessey Robert J of 223 shares of Genetic Technologies at 1.93 subject to Rule 16b-3 | 04/09/2024 |
5 | ASX Health Stocks GTG to establish pilot program in US using its geneType Breast Cancer Risk Test | 04/11/2024 |
6 | GeneType Clinicians Adoption Growing - Sales up 5-Fold Year on Year | 04/16/2024 |
7 | CGC, GENE and HOLO among mid-day movers | 04/18/2024 |
8 | Genetic Technologies Announces Closing of US2 Million Registered Direct Offering | 04/22/2024 |
Check out Genetic Technologies Hype Analysis, Genetic Technologies Correlation and Genetic Technologies Performance. For information on how to trade Genetic Stock refer to our How to Trade Genetic Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Complementary Tools for Genetic Stock analysis
When running Genetic Technologies' price analysis, check to measure Genetic Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genetic Technologies is operating at the current time. Most of Genetic Technologies' value examination focuses on studying past and present price action to predict the probability of Genetic Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genetic Technologies' price. Additionally, you may evaluate how the addition of Genetic Technologies to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
Is Genetic Technologies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genetic Technologies. If investors know Genetic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genetic Technologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 2.73 | Quarterly Revenue Growth (0.02) | Return On Assets (0.53) | Return On Equity (1.60) |
The market value of Genetic Technologies is measured differently than its book value, which is the value of Genetic that is recorded on the company's balance sheet. Investors also form their own opinion of Genetic Technologies' value that differs from its market value or its book value, called intrinsic value, which is Genetic Technologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genetic Technologies' market value can be influenced by many factors that don't directly affect Genetic Technologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genetic Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Genetic Technologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genetic Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.